Home Armagen

Armagen

acquired
Series A
Developer of Therapeutics for Neurological Disorders
Basic
Enterprise Profile

Basic Information

ArmaGen Aims to Transform the Treatment of Severe Neurological Disorders by Designing and Developing Revolutionary Brain Therapies. We Are Passionate About Science and Driven by the Opportunity to Change Patients' Lives. Our Team Advances Innovative Therapies with Speed and Skill, Both in Collaboration with Partners and as an Emerging Leader in the Fight Against Central Nervous System Diseases. The Company’s Pipeline of Innovative Therapies Can Penetrate the Blood-Brain Barrier to Treat Neurological Complications of Many Diseases, Including Lysosomal Storage Disorders (LSD), Alzheimer's, and Parkinson's, Offering Better Treatment for Patients with Neurodegenerative Diseases.
Armagen Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2001
contact@armagen.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
# Brain Sciences Therapeutic Products
Application Scenarios
Biologics Innovative Drugs